How Immunotherapy and Precision Medicine Are Shaping the Cancer Biological Therapy Market According to a newly published market research report by 24LifeSciences, the global cancer biological therapy market was valued at USD 93.2 billion in 2026 and is projected to reach USD 216.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.3% during the forecast period. Cancer biological therapy, often referred to as immunotherapy or biotherapy, represents a cutting-edge treatment approach that leverages the body's own immune system to combat cancer cells. This sophisticated modality works by either stimulating the immune system to enhance its natural defenses or by providing it with specialized components, such as laboratory-engineered immune system proteins, to precisely target and eliminate malignant cells. These therapies play a crucial role in treating various cancer types by preventing or slowing tumor growth and inhibiting the metastatic spread of the disease, offering a more targeted alternative to traditional chemotherapy and radiation treatments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9369/cancer-biological-therapy-market